PATENT CLAIM ANALYSIS

Application Number: 15745588
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "215000"]

Abstract:
Pharmaceutical compounds, compositions, and methods are presented in which various heterocyclic thiosemicarbazone derivatives are prepared. Contemplated compounds will be suitable to inhibit or reduce cellular growth or proliferation and are thus beneficial in the manufacture of drugs to treat neoplastic diseases.

Claim (Index 26):
The pharmaceutical composition of  claim 24 , wherein the composition is formulated for oral administration or injection.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14297526', '10850429', '14592628', '13809836', '13552460']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7511964034653401
- 35 USC 102 Novelty (BERT): 0.508814385134375
- Combined Prediction Score: 0.7269582016322437
- Mean Citation Score: 217.944202
- Max Citation Score: 222.50946
- Similarity Product: 132.09040301956415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test